J&J Led By Profits To Push Allegedly Faulty Mesh, Jury Told

By Matt Fair (December 3, 2018, 4:00 PM EST) -- The latest in a string of trials over injuries linked to a Johnson & Johnson unit's allegedly defective pelvic mesh products kicked off in Philadelphia as jurors heard arguments Monday that the company's thirst for profits pushed it to sell the implants despite serious concerns about patient safety.

Kline & Specter PC attorney Kila Baldwin told the jurors that J&J unit Ethicon knew that its implants were likely to cause women such as plaintiff Suzanne Emmet to experience complications, including the mesh sawing into the vagina, but that it had sold the products anyway as it looked to maintain market dominance....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!